SVB Leerink reiterated coverage on AdaptHealth with a new price target
$AHCO
Medical/Nursing Services
Health Care
SVB Leerink reiterated coverage of AdaptHealth with a rating of Outperform and set a new price target of $32.00 from $35.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/8/2024 | $14.50 → $8.00 | Buy → Hold | Jefferies |
| 11/8/2023 | $9.50 → $6.50 | Neutral → Underperform | BofA Securities |
| 5/10/2023 | $28.00 → $11.30 | Buy → Hold | Deutsche Bank |
| 5/10/2023 | $18.00 → $11.00 | Buy → Hold | Stifel |
| 5/9/2023 | $21.00 → $12.00 | Buy → Neutral | BofA Securities |
| 3/8/2022 | $31.00 → $26.00 | Outperform | RBC Capital |
| 3/2/2022 | $32.00 → $24.00 | Outperform | SVB Leerink |
| 2/18/2022 | $35.00 → $32.00 | Outperform | SVB Leerink |
10-K/A - AdaptHealth Corp. (0001725255) (Filer)
8-K - AdaptHealth Corp. (0001725255) (Filer)
SCHEDULE 13G - AdaptHealth Corp. (0001725255) (Subject)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
4 - AdaptHealth Corp. (0001725255) (Issuer)
Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously
BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously
Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously